# Grass Pollen Subcutaneous Immunotherapy in Elderly Patients

> **NCT02440243** · PHASE4 · COMPLETED · sponsor: **Medical University of Silesia** · enrollment: 120 (actual)

## Conditions studied

- Allergy

## Interventions

- **DRUG:** Purethal
- **DRUG:** Purethal -placebo

## Key facts

- **NCT ID:** NCT02440243
- **Lead sponsor:** Medical University of Silesia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02440243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02440243, "Grass Pollen Subcutaneous Immunotherapy in Elderly Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02440243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*